Evidence map›Paper›PMID 40454056›Full record

ArticleACS omega2025

Nanoformulations for Hydrazones; Synthesis, Characterization, Parasitology, and Histopathology Investigations.

Eman M Hassan, Ahmed R Rabee, Saied M Soliman, Mohamed Hagar, Esraa A Moneer, Sherif Ramadan, Assem Barakat, Hamida Abdel-Hamid, Ahmed Zakaria, Hanaa A Rasheed

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eman M HassanChemistry Department, Faculty of Science, Alexandria University, P.O. Box 426, Alexandria 21321, Egypt.
Ahmed R RabeeChemistry Department, Faculty of Science, Alexandria University, P.O. Box 426, Alexandria 21321, Egypt.
Saied M SolimanChemistry Department, Faculty of Science, Alexandria University, P.O. Box 426, Alexandria 21321, Egypt.ORCID https://orcid.org/0000-0001-8405-8370
Mohamed HagarChemistry Department, Faculty of Science, Alexandria University, P.O. Box 426, Alexandria 21321, Egypt.
Esraa A MoneerDepartment of Medical Laboratory Technology, Faculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria 21500, Egypt.
Sherif RamadanChemistry Department, Michigan State University, East Lansing 48824, Michigan, United States.ORCID https://orcid.org/0000-0002-8639-4105
Assem BarakatDepartment of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.ORCID https://orcid.org/0000-0002-7885-3201
Hamida Abdel-HamidChemistry Department, Faculty of Science, Alexandria University, P.O. Box 426, Alexandria 21321, Egypt.
Ahmed ZakariaChemistry Department, Faculty of Science, Alexandria University, P.O. Box 426, Alexandria 21321, Egypt.
Hanaa A RasheedChemistry Department, Faculty of Science, Alexandria University, P.O. Box 426, Alexandria 21321, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the creation of medicine delivery systems, nanotechnology has become an innovator, especially for organic compounds. The manipulation of materials at the nanoscale (1-100 nm) allows for unique physicochemical properties that can enhance the efficacy and bioavailability of therapeutic agents. The objective of the current research is to synthesize the hydrazones nanoparticles

Identifiers

PMID40454056
PMCPMC12120574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.